Newsroom
  • Press Releases
  • Presentations
Investors
  • Overview
  • Warrant Exercise Inquiries
  • Restricted Stock Inquiries
  • News / Events
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
Clinical Trial Enrollment
  • Triple-Negative Breast Cancer
  • COVID-19 Mild to Moderate
  • COVID-19 Severe or Critical
Contact

CytoDyn Inc.

  • Home
  • About CytoDyn
    • Meet CytoDyn
  • Our Science
  • Pipeline
    • Overview
    • HIV
    • Cancer
    • GVHD
    • COVID-19
  • Expanded Access
  • Our Team
    • Management Team
    • Board of Directors
  • Careers
    • Now Hiring
  • Scientific Board of Advisors
  • Newsroom
  • Investors
  • Clinical Trial Enrollment
  • Contact

FOR THE LATEST DEVELOPING NEWS

Click Here

Hospitals Enrolling COVID-19 Severe-to-Critical

Investment Community Webcast on Wednesday, January 6

Antibody-based strategies in HIV therapy

Dr. Seethamraju’s Presentation at Special isirv-AVG Virtual Conference

Manuscript Accepted by Infectious Diseases Society of America

Into the Looking Glass: Post-Viral Syndrome Post COVID-19

EUA for COVID-19 Vaccines and Treatments in the Philippines

Leronlimab’s Mechanism of Action in COVID-19 Published

Leronlimab role in COVID-19

Experimental Drugs Aim to Treat Long-Haul Covid Patients

Research on Critically Ill COVID-19 Patients Published in Journal of Translational Autoimmunity

Leronlimab and Long-Haulers

In The News

Investors

Investors

  • Overview
  • Warrant Exercise Inquiries
  • Restricted Stock Inquiries
  • News / Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar
  • Email Alerts

Proactive Investors: CytoDyn to submit trial designs of remdesivir vs leronlimab and in combination to battle coronavirus

May 18, 2020

Fox News: Biotech eyes COVID-19 treatment trial combining experimental coronavirus drugs leronlimab, remdesivir

May 18, 2020

Dr. Yo – Leronlimab, RANTES, COVID-19 (Coronavirus) Discussion with Dr. Bruce Patterson of IncellDX

May 17, 2020

Proactive Investors: CytoDyn partner to offer free testing for coronavirus-linked Childhood Inflammatory Disease

May 15, 2020

CBN News: 'I Thank God for Giving Me Another Day': Mom Credits Little-Known Drug Leronlimab with Saving Her Life

May 15, 2020

Spectrum News (Charlotte, NC): Novant Health Begins Testing a Treatment for Critically to Severely Sick COVID-19 Patients

May 14, 2020
Paper published in Nature mentions potential use of Leronlimab in COVID-19

Paper published in Nature mentions potential use of Leronlimab in COVID-19

May 14, 2020

Wall Street Reporter: CytoDyn (CYDY) NEXT SUPER STOCK livestream 5/13/20. Leronlimab COVID-19 treatment update

May 13, 2020

Targeted Oncology: FDA Advances Development of New Options for COVID-19 Prevention and Treatment

May 13, 2020

Dr. Yo – Coronavirus (COVID-19) Update: How RANTES can explain coronavirus symptoms | Leronlimab and RANTES

May 13, 2020
RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...13
  • Next »
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
© 2021 CytoDyn Inc. All Rights Reserved.
  • Twitter
  • Facebookj
Privacy Policy Disclaimer Sitemap